Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma

Clinical trial NCT04149275 · WITHDRAWN

Trial details

NCT number: NCT04149275
Sponsor: University of Alabama at Birmingham
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinosarcoma of Ovary Carcinosarcoma of Uterus Carcinosarcoma of Vagina

Start date: 2021-02-01
Primary completion: 2021-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.